
According to data from Benzinga Pro, during Q1, Chembio Diagnostics's (NASDAQ:CEMI) reported sales totaled $18.82 million. Despite a 37.09% increase in earnings, the company posted a loss of $8.79 million. In Q4, Chembio Diagnostics brought in $20.57 million in sales but lost $13.97 million in earnings.